Herath NI - Search Results

1

In Vivo Feasibility of Electrostatic Precipitation as an Adjunct to Pressurized Intraperitoneal Aerosol Chemotherapy (ePIPAC).

Kakchekeeva T, Demtröder C, Herath NI, Griffiths D, Torkington J, Solaß W, Dutreix M, Reymond MA. Kakchekeeva T, et al. Among authors: herath ni. Ann Surg Oncol. 2016 Dec;23(Suppl 5):592-598. doi: 10.1245/s10434-016-5108-4. Epub 2016 Feb 2. Ann Surg Oncol. 2016. PMID: 26842487 Free PMC article.

2

Pressurized intraluminal aerosol chemotherapy with Dbait in the distal esophagus of swine.

Khalili-Harbi N, Herath N, Solass W, Giger-Pabst U, Dutreix M, Reymond MA. Khalili-Harbi N, et al. Endoscopy. 2016 Feb;48(2):184-7. doi: 10.1055/s-0034-1393180. Epub 2015 Oct 13. Endoscopy. 2016. PMID: 26462086

3

The DNA Repair Inhibitor DT01 as a Novel Therapeutic Strategy for Chemosensitization of Colorectal Liver Metastasis.

Herath NI, Devun F, Lienafa MC, Herbette A, Denys A, Sun JS, Dutreix M. Herath NI, et al. Mol Cancer Ther. 2016 Jan;15(1):15-22. doi: 10.1158/1535-7163.MCT-15-0408. Epub 2015 Dec 4. Mol Cancer Ther. 2016. PMID: 26637369

4

Potentiation of doxorubicin efficacy in hepatocellular carcinoma by the DNA repair inhibitor DT01 in preclinical models.

Herath NI, Devun F, Herbette A, Lienafa MC, Chouteau P, Sun JS, Dutreix M, Denys A. Herath NI, et al. Eur Radiol. 2017 Oct;27(10):4435-4444. doi: 10.1007/s00330-017-4792-1. Epub 2017 Apr 3. Eur Radiol. 2017. PMID: 28374075

5

Preclinical Studies Comparing Efficacy and Toxicity of DNA Repair Inhibitors, Olaparib, and AsiDNA, in the Treatment of Carboplatin-Resistant Tumors.

Herath NI, Berthault N, Thierry S, Jdey W, Lienafa MC, Bono F, Noguiez-Hellin P, Sun JS, Dutreix M. Herath NI, et al. Front Oncol. 2019 Nov 12;9:1097. doi: 10.3389/fonc.2019.01097. eCollection 2019. Front Oncol. 2019. PMID: 31781480 Free PMC article.

6

The In Vivo Radiosensitizing Effect of Gold Nanoparticles Based MRI Contrast Agents.

Miladi I, Alric C, Dufort S, Mowat P, Dutour A, Mandon C, Laurent G, Bräuer-Krisch E, Herath N, Coll JL, Dutreix M, Lux F, Bazzi R, Billotey C, Janier M, Perriat P, Le Duc G, Roux S, Tillement O. Miladi I, et al. Small. 2014 Feb 4. doi: 10.1002/smll.201302303. Online ahead of print. Small. 2014. PMID: 24677791

7

The in vivo radiosensitizing effect of gold nanoparticles based MRI contrast agents.

Miladi I, Alric C, Dufort S, Mowat P, Dutour A, Mandon C, Laurent G, Bräuer-Krisch E, Herath N, Coll JL, Dutreix M, Lux F, Bazzi R, Billotey C, Janier M, Perriat P, Le Duc G, Roux S, Tillement O. Miladi I, et al. Small. 2014 Mar 26;10(6):1116-24. doi: 10.1002/smll.201470036. Small. 2014. PMID: 24659273

8

Minor changes in the macrocyclic ligands but major consequences on the efficiency of gold nanoparticles designed for radiosensitization.

Laurent G, Bernhard C, Dufort S, Jiménez Sánchez G, Bazzi R, Boschetti F, Moreau M, Vu TH, Collin B, Oudot A, Herath N, Requardt H, Laurent S, Vander Elst L, Muller R, Dutreix M, Meyer M, Brunotte F, Perriat P, Lux F, Tillement O, Le Duc G, Denat F, Roux S. Laurent G, et al. Nanoscale. 2016 Jun 9;8(23):12054-65. doi: 10.1039/c6nr01228k. Nanoscale. 2016. PMID: 27244570

9

Epigenetic silencing of EphA1 expression in colorectal cancer is correlated with poor survival.

Herath NI, Doecke J, Spanevello MD, Leggett BA, Boyd AW. Herath NI, et al. Br J Cancer. 2009 Apr 7;100(7):1095-102. doi: 10.1038/sj.bjc.6604970. Epub 2009 Mar 10. Br J Cancer. 2009. PMID: 19277044 Free PMC article.

10

The role of Eph receptors and ephrin ligands in colorectal cancer.

Herath NI, Boyd AW. Herath NI, et al. Int J Cancer. 2010 May 1;126(9):2003-11. doi: 10.1002/ijc.25147. Int J Cancer. 2010. PMID: 20039322 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

26 results

Search Page